As the consumer demands less input of antibiotics in livestock, there is a growing concern to livestock health and the protection of the growers and integrators investment. What are the alternatives?
Dr. Peter Davies - Antibiotic use and resistance: How did we get here and whe...John Blue
Antibiotic use and resistance: How did we get here and where are we headed? - Dr. Peter Davies, University of Minnesota, from the 2016 Minnesota Pork Congress, January 18 - 20, 2016, Minneapolis, MN, USA.
More presentations at http://www.swinecast.com/2016-minnesota-pork-congress
Dr. Terry Coffey - Retail Panel on Stewardship Programs - SmithfieldJohn Blue
Retail Panel on Stewardship Programs - Smithfield - Dr. Terry Coffey, Chief Science and Technology Officer, Smithfield Foods, from the 2016 NIAA Antibiotic Symposium - Working Together For Better Solutions, November 1 - 3, 2016, Herndon, Virginia, USA.
More presentations at http://www.swinecast.com/2016-niaa-symposium-antibiotic-use-working-together-for-better-solutions
Dr. Paul Ruen - The future of Antibiotic Use: Are you, your feed mill and vet...John Blue
The future of Antibiotic Use: Are you, your feed mill and veterinarian ready for January 1, 2017? How did we get here? What does it mean? - Dr. Paul Ruen, Fairmont Veterinary Clinic, from the 2016 Minnesota Pork Congress, January 18 - 20, 2016, Minneapolis, MN, USA.
More presentations at http://www.swinecast.com/2016-minnesota-pork-congress
First World Antibiotic Awareness Week and awareness campaigns on prudent antibiotic use extended throughout the WHO European Region - presentation delivered by Dr Zsuzsanna Jakab, Regional Director, WHO Regional Office for Europe, on 16 November 2015
Dr. Mike Apley - Antibiotics in the Future Tense: How the Last 5 Years Have S...John Blue
Antibiotics in the Future Tense: How the Last 5 Years Have Set the Course - Dr. Mike Apley, College of Veterinary Medicine, Kansas State University, from the 2017 Minnesota Pork Congress, January 17 - 18, 2017, Minneapolis, MN, USA.
More presentations at http://www.swinecast.com/2017-minnesota-pork-congress
Dr. Peter Davies - Antibiotic use and resistance: How did we get here and whe...John Blue
Antibiotic use and resistance: How did we get here and where are we headed? - Dr. Peter Davies, University of Minnesota, from the 2016 Minnesota Pork Congress, January 18 - 20, 2016, Minneapolis, MN, USA.
More presentations at http://www.swinecast.com/2016-minnesota-pork-congress
Dr. Terry Coffey - Retail Panel on Stewardship Programs - SmithfieldJohn Blue
Retail Panel on Stewardship Programs - Smithfield - Dr. Terry Coffey, Chief Science and Technology Officer, Smithfield Foods, from the 2016 NIAA Antibiotic Symposium - Working Together For Better Solutions, November 1 - 3, 2016, Herndon, Virginia, USA.
More presentations at http://www.swinecast.com/2016-niaa-symposium-antibiotic-use-working-together-for-better-solutions
Dr. Paul Ruen - The future of Antibiotic Use: Are you, your feed mill and vet...John Blue
The future of Antibiotic Use: Are you, your feed mill and veterinarian ready for January 1, 2017? How did we get here? What does it mean? - Dr. Paul Ruen, Fairmont Veterinary Clinic, from the 2016 Minnesota Pork Congress, January 18 - 20, 2016, Minneapolis, MN, USA.
More presentations at http://www.swinecast.com/2016-minnesota-pork-congress
First World Antibiotic Awareness Week and awareness campaigns on prudent antibiotic use extended throughout the WHO European Region - presentation delivered by Dr Zsuzsanna Jakab, Regional Director, WHO Regional Office for Europe, on 16 November 2015
Dr. Mike Apley - Antibiotics in the Future Tense: How the Last 5 Years Have S...John Blue
Antibiotics in the Future Tense: How the Last 5 Years Have Set the Course - Dr. Mike Apley, College of Veterinary Medicine, Kansas State University, from the 2017 Minnesota Pork Congress, January 17 - 18, 2017, Minneapolis, MN, USA.
More presentations at http://www.swinecast.com/2017-minnesota-pork-congress
The use of antimicrobial in humans and animals, the consequences of this use, the political and economic barriers to improve prudent use and possible solutions for this problem.
Edible vaccines are produced by genetically engineering plants and animals to contain antigens that trigger an immune response. When ingested, the antigens are delivered through the digestive system and taken up by immune cells to produce antibodies and memory cells, protecting against disease. Different plants have been studied for their ability to serve as edible vaccines, including potato, banana, rice and tomato. Each has advantages like ease of growth or administration, but also challenges like stability of antigens or variable dosing. Edible vaccines could provide a low-cost, easy to distribute method for vaccination programs in developing areas.
Edible vaccines are genetically engineered foods that contain antigens to produce an immune response against infections and diseases. They are administered orally by eating the food and induce both mucosal and systemic immunity. The antigens in edible vaccines break down in the Peyer's patches and activate B-cells to produce antibodies that provide mucosal immunity. Edible vaccines have been explored for diseases like diabetes, cholera, malaria, and measles. They offer advantages like low-cost mass production and distribution without needing medical facilities but also have challenges in maintaining consistent dosages. Future prospects include approval by WHO and production of edible vaccines for other major diseases.
Felicia Wu
John A. Hannah Distinguished Professor
Department of Food Science and Human Nutrition
Department of Agricultural, Food, and Resource Economics
The overuse of antibiotics in livestock is contributing to the growing problem of antibiotic resistance in humans. To promote growth and prevent disease, livestock are routinely fed antibiotics, even when they are not sick. This widespread antibiotic use has led to drug-resistant bacteria in animals that can be transmitted to humans. With antibiotic resistance posing a major threat to public health, regulating antibiotic use in agriculture and restricting them to therapeutic use only in sick animals is crucial to solving this crisis.
World Veterinary Day 2017 Presentation made at the College of Veterinary and Animal Science, Navania, Vallabhnagar, Udaipur by DR. BALWANT MESHRAM on the topic 'WVD: Past and the Present'
Presentation of Edible Vaccine, Properties of an edible vaccine, how to make an edible vaccine, and etc.
An edible vaccine is the best vaccine for developing country because of it very cost effective and very simple to use.
But our country has not developed this vaccine yet. So it is our responsibility to develop an edible vaccine to protect our human being form more infectious disease.
Overview of Laws Regulating Antibiotics in Livestock & Policy Positions of St...Cari Rincker
This was prepared for a presentation for the Association for the Bar for the City of New York's Committee on Animal Law & Health Law Committee. Outline with more detail and citations is available at http://www.jdsupra.com/legalnews/overviews-of-laws-regulating-antibiotics-15572/.
Plant-derived vaccines offer several potential advantages over traditional vaccines. Genetically modified plants can produce vaccine antigens that can then be extracted and purified for use. These vaccines could be administered either orally or applied to mucosal surfaces. Plant-derived vaccines may be cheaper to produce at large scales using crops like potatoes and corn. The antigens would also be more stable and could be stored longer. However, some technical challenges around safety and regulation must still be addressed before plant-derived vaccines can be widely used.
Curtiss Healthcare is developing novel orally-delivered live recombinant attenuated Salmonella vector (RASV) vaccines to prevent infectious diseases in animals and humans. They have licensed over 100 patents from 3 universities. Their initial focus is on improving food safety and quality in poultry and swine through vaccines targeting diseases like necrotic enteritis, Campylobacter, and Salmonella. Their most advanced vaccine targets necrotic enteritis caused by Clostridium perfringens in poultry and has shown efficacy in studies. They are seeking $12-15 million in Series A funding to advance 5-6 additional vaccines.
Dr. Brian Lubbers - Animal Agriculture's Contribution to Antibiotic Resistanc...John Blue
Animal Agriculture's Contribution to Antibiotic Resistance - What Should (& Should Not) Be On The Table - Dr. Brian Lubbers, Kansas State University College of Veterinary Medicine, Director of Clinical Microbiology, from the 2014 NIAA Symposium on Antibiotics Use and Resistance: Moving Forward Through Shared Stewardship, November 12-14, 2014, Atlanta, Georgia, USA.
More presentations at http://www.swinecast.com/2014-niaa-antibiotics-moving-forward-through-shared-stewardship
Is Your Meat Safe? How Are Antibiotics Negatively Impacting the Health of Fee...PhoebeSeto
The document discusses the overuse of antibiotics in concentrated animal feeding operations (CAFOs) and its consequences. It notes that 80% of antibiotics sold in the US are for livestock use, primarily to promote growth and prevent disease in crowded conditions. This widespread antibiotic use has led to the evolution and spread of antibiotic-resistant bacteria, threatening human health by rendering some life-saving drugs ineffective. It estimates that antibiotic resistance will kill 10 million people annually by 2050 if changes are not made. Solutions proposed include limiting antibiotic use to sick animals only and improved food labeling regarding antibiotic use.
This document discusses vaccines and the potential for using plants as bioreactors to produce vaccines. It notes that vaccines provide active immunity against diseases and typically contain weakened or killed forms of pathogens. Vaccination is an effective public health measure. Recently, genetically engineering plants to express antigen proteins from pathogens has emerged as a way to develop subunit vaccines more economically than traditional methods. The document outlines opportunities like safety, immune response, stability, low cost, and challenges like regulatory concerns for plant-based vaccines. It provides examples of plant-made influenza vaccines in development that could allow rapid production in response to pandemics.
NRDC ISSUe brIeF
Playing Chicken with Antibiotics:
Previously Undisclosed FDA Documents Show Antibiotic Feed Additives Don’t Meet the Agency’s Own Safety Standards
Intensive care units are considered epicenters of antibiotic resistance due to the frequent use of broad-spectrum antibiotics for critically ill patients, close proximity of patients allowing transmission of resistant bacteria, and presence of chronically ill patients who may harbor resistant bacteria. The overuse of antibiotics in ICUs places significant selective pressure on bacteria to develop resistance. Infections caused by resistant bacteria in ICUs have major impacts on patient outcomes and healthcare costs. Strategies to reduce the emergence and transmission of resistant bacteria in ICUs include minimizing antibiotic use through improved prescribing and surveillance of resistance patterns, implementing strict infection control measures, and optimizing antibiotic therapy based on culture results.
Integrated Pest Management (IPM) is an ecosystem approach to crop production that combines different management strategies to minimize pesticide use and grow healthy crops. IPM relates to controlling insects, weeds, diseases and other pests through integrated use of cultural, biological and chemical methods. Many farmers are already practicing IPM to some degree without realizing it, through actions like crop rotation, scouting, and removing infested plant material. Taking IPM further involves encouraging natural predators, more intensive scouting, and using additional techniques like cover crops and intercropping to better prepare against potential pest problems.
Healthy animals for healthy lives in low- and middle-income countriesILRI
Presented by Hung Nguyen, Vish Nene, Delia Grace Randolph, Silvia Alonso, Charity Kinyua, Nicholas Svitek, Elise Schieck, Bernard Bett, Fred Unger, Hussein Abkallo, Kristina Roesel and Sinh Dang-Xuan at the Tropentag 2021―Towards shifting paradigms in agriculture for a healthy and sustainable future, 15-17 September 2021
1) Skinomics is defining the human skin microbiome through genomic sequencing and databases to develop probiotic therapeutics as alternatives to antibiotics for skin diseases like acne.
2) Their first product is a skin-derived probiotic to treat acne by restoring healthy bacteria that outcompete acne-causing bacteria, with the goal of obtaining FDA approval.
3) If successful, they plan to expand probiotic treatments to other common skin diseases where bacteria play a role, like eczema and psoriasis, while also pursuing diagnostic tests and drug discovery through their skin microbiome databases.
The use of antimicrobial in humans and animals, the consequences of this use, the political and economic barriers to improve prudent use and possible solutions for this problem.
Edible vaccines are produced by genetically engineering plants and animals to contain antigens that trigger an immune response. When ingested, the antigens are delivered through the digestive system and taken up by immune cells to produce antibodies and memory cells, protecting against disease. Different plants have been studied for their ability to serve as edible vaccines, including potato, banana, rice and tomato. Each has advantages like ease of growth or administration, but also challenges like stability of antigens or variable dosing. Edible vaccines could provide a low-cost, easy to distribute method for vaccination programs in developing areas.
Edible vaccines are genetically engineered foods that contain antigens to produce an immune response against infections and diseases. They are administered orally by eating the food and induce both mucosal and systemic immunity. The antigens in edible vaccines break down in the Peyer's patches and activate B-cells to produce antibodies that provide mucosal immunity. Edible vaccines have been explored for diseases like diabetes, cholera, malaria, and measles. They offer advantages like low-cost mass production and distribution without needing medical facilities but also have challenges in maintaining consistent dosages. Future prospects include approval by WHO and production of edible vaccines for other major diseases.
Felicia Wu
John A. Hannah Distinguished Professor
Department of Food Science and Human Nutrition
Department of Agricultural, Food, and Resource Economics
The overuse of antibiotics in livestock is contributing to the growing problem of antibiotic resistance in humans. To promote growth and prevent disease, livestock are routinely fed antibiotics, even when they are not sick. This widespread antibiotic use has led to drug-resistant bacteria in animals that can be transmitted to humans. With antibiotic resistance posing a major threat to public health, regulating antibiotic use in agriculture and restricting them to therapeutic use only in sick animals is crucial to solving this crisis.
World Veterinary Day 2017 Presentation made at the College of Veterinary and Animal Science, Navania, Vallabhnagar, Udaipur by DR. BALWANT MESHRAM on the topic 'WVD: Past and the Present'
Presentation of Edible Vaccine, Properties of an edible vaccine, how to make an edible vaccine, and etc.
An edible vaccine is the best vaccine for developing country because of it very cost effective and very simple to use.
But our country has not developed this vaccine yet. So it is our responsibility to develop an edible vaccine to protect our human being form more infectious disease.
Overview of Laws Regulating Antibiotics in Livestock & Policy Positions of St...Cari Rincker
This was prepared for a presentation for the Association for the Bar for the City of New York's Committee on Animal Law & Health Law Committee. Outline with more detail and citations is available at http://www.jdsupra.com/legalnews/overviews-of-laws-regulating-antibiotics-15572/.
Plant-derived vaccines offer several potential advantages over traditional vaccines. Genetically modified plants can produce vaccine antigens that can then be extracted and purified for use. These vaccines could be administered either orally or applied to mucosal surfaces. Plant-derived vaccines may be cheaper to produce at large scales using crops like potatoes and corn. The antigens would also be more stable and could be stored longer. However, some technical challenges around safety and regulation must still be addressed before plant-derived vaccines can be widely used.
Curtiss Healthcare is developing novel orally-delivered live recombinant attenuated Salmonella vector (RASV) vaccines to prevent infectious diseases in animals and humans. They have licensed over 100 patents from 3 universities. Their initial focus is on improving food safety and quality in poultry and swine through vaccines targeting diseases like necrotic enteritis, Campylobacter, and Salmonella. Their most advanced vaccine targets necrotic enteritis caused by Clostridium perfringens in poultry and has shown efficacy in studies. They are seeking $12-15 million in Series A funding to advance 5-6 additional vaccines.
Dr. Brian Lubbers - Animal Agriculture's Contribution to Antibiotic Resistanc...John Blue
Animal Agriculture's Contribution to Antibiotic Resistance - What Should (& Should Not) Be On The Table - Dr. Brian Lubbers, Kansas State University College of Veterinary Medicine, Director of Clinical Microbiology, from the 2014 NIAA Symposium on Antibiotics Use and Resistance: Moving Forward Through Shared Stewardship, November 12-14, 2014, Atlanta, Georgia, USA.
More presentations at http://www.swinecast.com/2014-niaa-antibiotics-moving-forward-through-shared-stewardship
Is Your Meat Safe? How Are Antibiotics Negatively Impacting the Health of Fee...PhoebeSeto
The document discusses the overuse of antibiotics in concentrated animal feeding operations (CAFOs) and its consequences. It notes that 80% of antibiotics sold in the US are for livestock use, primarily to promote growth and prevent disease in crowded conditions. This widespread antibiotic use has led to the evolution and spread of antibiotic-resistant bacteria, threatening human health by rendering some life-saving drugs ineffective. It estimates that antibiotic resistance will kill 10 million people annually by 2050 if changes are not made. Solutions proposed include limiting antibiotic use to sick animals only and improved food labeling regarding antibiotic use.
This document discusses vaccines and the potential for using plants as bioreactors to produce vaccines. It notes that vaccines provide active immunity against diseases and typically contain weakened or killed forms of pathogens. Vaccination is an effective public health measure. Recently, genetically engineering plants to express antigen proteins from pathogens has emerged as a way to develop subunit vaccines more economically than traditional methods. The document outlines opportunities like safety, immune response, stability, low cost, and challenges like regulatory concerns for plant-based vaccines. It provides examples of plant-made influenza vaccines in development that could allow rapid production in response to pandemics.
NRDC ISSUe brIeF
Playing Chicken with Antibiotics:
Previously Undisclosed FDA Documents Show Antibiotic Feed Additives Don’t Meet the Agency’s Own Safety Standards
Intensive care units are considered epicenters of antibiotic resistance due to the frequent use of broad-spectrum antibiotics for critically ill patients, close proximity of patients allowing transmission of resistant bacteria, and presence of chronically ill patients who may harbor resistant bacteria. The overuse of antibiotics in ICUs places significant selective pressure on bacteria to develop resistance. Infections caused by resistant bacteria in ICUs have major impacts on patient outcomes and healthcare costs. Strategies to reduce the emergence and transmission of resistant bacteria in ICUs include minimizing antibiotic use through improved prescribing and surveillance of resistance patterns, implementing strict infection control measures, and optimizing antibiotic therapy based on culture results.
Integrated Pest Management (IPM) is an ecosystem approach to crop production that combines different management strategies to minimize pesticide use and grow healthy crops. IPM relates to controlling insects, weeds, diseases and other pests through integrated use of cultural, biological and chemical methods. Many farmers are already practicing IPM to some degree without realizing it, through actions like crop rotation, scouting, and removing infested plant material. Taking IPM further involves encouraging natural predators, more intensive scouting, and using additional techniques like cover crops and intercropping to better prepare against potential pest problems.
Healthy animals for healthy lives in low- and middle-income countriesILRI
Presented by Hung Nguyen, Vish Nene, Delia Grace Randolph, Silvia Alonso, Charity Kinyua, Nicholas Svitek, Elise Schieck, Bernard Bett, Fred Unger, Hussein Abkallo, Kristina Roesel and Sinh Dang-Xuan at the Tropentag 2021―Towards shifting paradigms in agriculture for a healthy and sustainable future, 15-17 September 2021
1) Skinomics is defining the human skin microbiome through genomic sequencing and databases to develop probiotic therapeutics as alternatives to antibiotics for skin diseases like acne.
2) Their first product is a skin-derived probiotic to treat acne by restoring healthy bacteria that outcompete acne-causing bacteria, with the goal of obtaining FDA approval.
3) If successful, they plan to expand probiotic treatments to other common skin diseases where bacteria play a role, like eczema and psoriasis, while also pursuing diagnostic tests and drug discovery through their skin microbiome databases.
Antibiotic resistance is one of the biggest threats to global health today. When bacteria become resistant to antibiotics, common infections become harder to treat and even deadly. The overuse and misuse of antibiotics is accelerating this problem. Urgent action is needed across all sectors including changes in how antibiotics are prescribed and used by individuals, farmers, health systems and policymakers to preserve the effectiveness of antibiotics and reduce the spread of resistant infections. The WHO has created a global action plan with initiatives to improve awareness, surveillance, infection prevention and optimize antibiotic use to tackle this growing public health crisis.
Dr. Amy Batal - Antibiotic Stewardship Update ProgressJohn Blue
Antibiotic Stewardship Update Progress - Dr. Roger Saltman, Group Director Cattle and Equine Technical Services, Zoetis; Ms. Shannon Wharton, Research Manager, Hy-Plains Feedyard; Mr. Joe Swedberg, Chairman of the Board, Farm Foundation, Hormel Foods Corporation (retired); Dr. William T. Flynn, Deputy Director, Science Policy, Center for Veterinary Medicine, FDA; Dr. Amy Batal, Corporate Nutritionist, Sanderson Farms, from the 2017 NIAA Antibiotic Symposium - Antibiotic Stewardship: Collaborative Strategy for Animal Agriculture and Human Health, October 31 - November 2, 2017, Herndon, Virginia, USA.
More presentations at http://www.swinecast.com/2017-niaa-antibiotic-symposium-antibiotic-stewardship
Dr. Peter Davies - How Scientific Advances Are Being Used To Meet Consumers' ...John Blue
How Scientific Advances Are Being Used To Meet Consumers' Needs And Ensure Public Health - Dr. Peter Davies, Professor, University of Minnesota, from the 2018 NIAA Antibiotic Symposium: New Science & Technology Tools for Antibiotic Stewardship, November 13-15, 2018, Overland Park, KS, USA.
More presentations at https://www.youtube.com/playlist?list=PL8ZKJKD9cmEffjOrjbBvQZeN2_SZB_Skc
This document discusses the role of antibiotics in animal feed and the development of antibiotic resistance. It notes that antibiotic resistance first emerged as an intrinsic property in some bacteria and later developed through selective pressure from antibiotic exposure. The routine use of antibiotics as growth promoters in food animals is identified as a serious public health issue as it can create a reservoir of resistant bacteria that spread to humans. The document argues that antibiotics should not be used as growth promoters and only be used prudently for therapy and prophylaxis to minimize resistance. Adopting principles like restricting antibiotics critical for human medicine and minimizing prophylactic use could substantially reduce unnecessary antibiotic resistance.
The document discusses the importance of developing an antibiotic policy to improve antibiotic use and combat antibiotic resistance. It notes that overuse and misuse of antibiotics in various healthcare, agricultural, and community settings has contributed significantly to the rise of antibiotic-resistant bacteria. An antibiotic policy aims to standardize and promote best practices for antibiotic prophylaxis and treatment. It also seeks to improve education, optimize resource use, and slow the emergence and spread of resistant bacteria. Developing effective antibiotic stewardship requires coordinated efforts between clinicians, microbiologists, pharmacists, and other stakeholders. Ongoing monitoring of resistance patterns and prudent prescribing guided by local susceptibility data are also emphasized.
In India, bacteria that cause common infections, such as urinary tract and bloodstream infections, are becoming resistant to nearly all antibiotics. This resistance is due to a combination of factors: uncontrolled access to antibiotics, gaps in infection prevention and control (IPC) practices, and high rates of communicable diseases. Antibiotic resistance, or AR, is a serious problem throughout the country, and threatens to reduce the usefulness of antibiotics both in India and around the world.
Because of this emerging threat, India is committed to slowing the spread of AR. Two institutions within India’s Ministry of Health – the Indian Council of Medical Research and National Centre for Disease Control – each developed national networks of public and private hospitals to measure AR trends, prevent healthcare-associated infections (HAIs), and enhance appropriate use of antibiotics. The All India Institute of Medical Sciences is coordinating HAI measurement and prevention efforts in both networks. In addition, efforts in the state of Tamil Nadu focus on building district-level IPC capacity to prevent HAIs, focusing on maternal and neonatal patients.
The Indian Governamnet is is working closely with partners at the national and state level to:
Detect AR pathogens, including novel strains, by developing lab networks and lab expertise.
Use standardized surveillance to monitor and track AR infections in healthcare to learn how often these infections occur and to help develop strategies to prevent them.
Implement focused IPC activities and training.
Optimize use and reduce misuse of critical antibiotics through antibiotic stewardship programs.
The overuse of antibiotics in both human medicine and agricultural practices has led to a growing problem of antibiotic resistance. When antibiotics are used to promote growth in farm animals, resistant bacteria can be passed to humans through meat consumption and spread among populations. If antibiotic resistance continues to increase, many infections could become untreatable, returning the world to a pre-antibiotic era. Reducing unnecessary antibiotic use in both medicine and agriculture is necessary to slow the development of resistance and preserve the effectiveness of these drugs.
Dr. Donna Carver - Science and Practice - How does the Science of Antibiotic ...John Blue
Science and Practice - How does the Science of Antibiotic Resistance and Use Get Applied in Veterinary and Farming Practices? - Dr. Eric Moore, Technical Director, Norbrook, Inc., Dr. H. Morgan Scott, Professor of Epidemiology, Texas A&M; Dr. Donna Carver, Extension Specialist, Poultry Veterinarian, North Carolina State University; Dr. Joel Nerem, Pipestone Veterinary Services, from the 2017 NIAA Antibiotic Symposium - Antibiotic Stewardship: Collaborative Strategy for Animal Agriculture and Human Health, October 31 - November 2, 2017, Herndon, Virginia, USA.
More presentations at http://www.swinecast.com/2017-niaa-antibiotic-symposium-antibiotic-stewardship
Bacteriophages for Promoting Human Health and Advancing Environmental Sustain...Alys Spillman
Intralytix is developing bacteriophage-based products that use viruses to target and kill specific bacteria. These natural products provide environmentally friendly alternatives to antibiotics and chemicals for applications in food safety, environmental cleanup, healthcare, and more. Bacteriophages only kill their targeted bacteria and do not harm other species, making them a precise and sustainable tool for controlling diseases and maintaining microbial balance. Intralytix is working to commercialize these phage-based products to improve food safety, reduce antibiotic resistance, and promote human and environmental health in a green way.
Bacteriophages for Promoting Human Health and Advancing Environmental Sustain...Alys Spillman
Intralytix is developing bacteriophage-based products that use viruses to target and kill specific bacteria. These natural products provide environmentally friendly alternatives to antibiotics and chemicals for applications in food safety, environmental cleanup, healthcare, and more. Bacteriophages only kill their targeted bacteria and do not harm other species, making them a precise and sustainable tool for controlling diseases and maintaining microbial balance. Intralytix is working to commercialize these phage-based products to improve food safety, reduce antibiotic resistance, and promote human and environmental health in a green way.
Dr. Cyril Gay - Alternatives to AntibioticsJohn Blue
Alternatives to Antibiotics - Dr. Cyril Gay, Senior National Program Manager, USDA Agricultural Research Service (ARS), from the 2017 NIAA Annual Conference, U.S. Animal Agriculture's Future Role In World Food Production - Obstacles & Opportunities, April 4 - 6, Columbus, OH, USA.
More presentations at http://www.trufflemedia.com/agmedia/conference/2017_niaa_us_animal_ag_future_role_world_food_production
The Johns Hopkins Center for a Livable Future Capitol Hill Briefing: Antibiot...Johns Hopkins University
This Congressional briefing document discusses the growing crisis of antibiotic resistance and its enormous economic and public health impacts. It notes that antibiotic resistant infections result in more deaths and disability and cost the healthcare system billions annually in increased costs and lost productivity. The overuse of antibiotics in agriculture also contributes to the rise of resistant bacteria, with millions of pounds used annually in food animals often just for growth promotion rather than therapeutic purposes. Presenters recommend banning the non-therapeutic use of antibiotics in food animal production, increasing veterinary oversight of antibiotic use, and improving monitoring and surveillance of antibiotic resistance in both the healthcare and agricultural sectors.
The document discusses biopesticides as alternatives to synthetic pesticides. It describes three main categories of biopesticides - microbial pesticides, plant-incorporated protectants, and biochemical pesticides. Microbial pesticides use microorganisms as the active ingredient, while plant-incorporated protectants involve genetic modification of plants. Biochemical pesticides control pests through non-toxic mechanisms. The document also reviews advantages and limitations of biopesticides, market trends, competitors in the biopesticides industry, and regulatory information from the EPA.
Farmers use antibiotics to keep livestock healthy and food safe. Antibiotics treat and prevent bacterial infections in animals just as they do in humans. The FDA approves antibiotics for use in animals and determines withdrawal periods to ensure meat is antibiotic-free. Multiple agencies regularly test food to ensure it is safe. While antibiotic overuse can lead to resistance, farmers and veterinarians are working to prevent this through judicious use and separating medically important human antibiotics.
This document summarizes the industrialization and privatization of biotechnology. It discusses how biotechnology has become integrated into many products and agriculture after World War 2 to keep up with growing population demands. Private funding now fuels over half of agricultural research and development, focusing on establishing product markets. While biotechnology benefits society, private interests prioritize profits. The document also examines the case of Monsanto corn and debates around health risks versus economic benefits of genetically modified crops.
This document discusses how genetic engineering can be used to reduce antibiotic use in animal agriculture. It notes that overuse of antibiotics in food animals promotes antibiotic resistance. Genetic modifications like accelerated growth, disease resistance, and large product yields could provide viable alternatives to meet industry needs while reducing antibiotic use. The document explores how new gene editing tools like CRISPR could be applied to genetically modify farm animals and increase their immunity. However, it also notes there are some concerns about animal welfare and unintended consequences of genetic modifications that require further research.
It is not a secret that for the cultivation of farm animals antibiotics are used. Usually, antibiotics in meat industry are used to prevent bacterial infections. However, antibiotics have been used quite often for stimulation of a rapid growth of animals in these latter days.
Similar to Antibiotics vs disinfectants vs genetics (20)
1. Antibiotics VS Disinfectants VS Genetics
Depending on the type of production all 3 are commonly used in today’s livestock production. Although
an antibiotic free production would not use antibiotics of course, especially an organic operation.
Genetics seem to be widely used whether you realize it or not. Though this is a matter of another article
we will save for later. But it seems that the most common denominator to help prevent the spread of
infectious diseases, viruses and bacteria is the use of some type of disinfectant.
Consumer Demand & Livestock health, finding a balance
As the consumer demands less input of antibiotics in livestock, there is a growing concern to livestock
health and the protection of the growers and integrators investment. Without antibiotics animals are
more susceptible to disease, viruses and other pathogens that can cause the mortality rate of the
livestock to skyrocket at a seemingly unstoppable rate. So what are the options?
Research and development farms are continually improving the breeding stock of multiple breeds of
livestock. From breeds that are more resistant to certain types of disease or conditions caused by the
environmental surroundings of the livestock housing facilities, to breeds that will convert feed at a
higher rate in order to take full advantage of the nutrients found in that feed. Both can help to increase
the integrators and the growers ROI and produce a quality product for the end consumer.
Even though creating stronger breeding stock seems to be a viable solution to the reduction of
antibiotics and still being able to produce a product that is economical for the consumer’s demands, it
still is not without its own challenges; especially in the mind of the uninformed consumer. This form of
genetic manipulation is misunderstood, and thus has received public criticism from certain uninformed
groups.
So, are there economical and practical alternatives?
So, where can an industry that is under an extreme amount of criticism from a uniformed public, gain
ground when it comes to protecting its investment against infectious diseases and pathogens while
trying to give the consumer what it demands? If you reduce one area of fighting disease, it only makes
sense to strengthen efforts somewhere else, but where? By reducing the amount of pathogens in the
housing facilities and the livestock farm it’s self.
Infectious diseases are the largest cause of financial loss to a livestock producer there is. From bacterial
to virucidal, from AI to coccidiosis all conditions that have been treated or prevented through the
administering of vaccinations or antibiotics. So if this type of treatment is eliminated where do
producers turn to protect the health of the livestock? It has to be in prevention. This prevention is in an
increased proactive approach to biosecurity.
But, what is biosecurity? It is procedures intended to protect humans or animals against
disease or harmful biological agents. So how do we protect livestock against biosecurity threats?
2. First of all, we need to establish a specific plan or biosecurity protocol for all areas of live production at
the farm level. All areas are included, a barn (or live housing facility) protocol, an equipment protocol, a
vehicle protocol and an entrance protocol. These protocols may include more of the previously
mentioned, and all the protocols make up a biosecurity plan.
All these protocols have a common denominator, they all include a way to kill, destroy or contain
potential biosecurity threats, usually through the use of an antimicrobial product or disinfectant. The
best disinfectants are ones that can safely be handled, safely dispensed, and safe for the environment.
The proactive use of disinfectants and the equipment used to dispense them can help offset the non-use
of antibiotics as effectively as any improved breed stock.
Of course to have an effective biosecurity plan, everyone involved or visiting the farm for any reason
needs to be completely aware of the plan and always follow it according to procedure. Even the best can
be compromised if just one person fails to follow even part of it.
Keep a look out for the next article on Establishing A Biosecurity Protocol and the tools available to help.
By
Kent Schrum